Listed

TherapeuticsMD, Inc.

TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31

Reports and events: 392 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

TherapeuticsMD, Inc., Reports and events
FiledFormWhat it isAccession number
2015-08-0716:49 ET10-QQuarterly reportPeriod 2015-06-300001387131-15-002352
2015-08-0616:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-15-002323
2015-07-1516:33 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-15-253673
2015-06-2308:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-15-001982
2015-06-1517:07 ET8-K5.07 Shareholder vote results0001387131-15-001944
2015-06-0907:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-15-001914
2015-05-0717:00 ET10-QQuarterly reportPeriod 2015-03-310001387131-15-001534
2015-05-0516:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-15-001467
2015-04-3020:20 ETDEF 14AProxy statementPeriod 2015-06-110001193125-15-157717
2015-03-3116:34 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001387131-15-001139
2015-03-1808:22 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-15-000921
2015-03-1216:36 ET10-KAnnual reportPeriod 2014-12-310001387131-15-000875
2015-03-1016:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-15-000813
2015-02-1717:29 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001387131-15-000590
2015-01-1216:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-15-000068
2014-11-1808:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-14-003839
2014-11-0717:04 ET10-QQuarterly reportPeriod 2014-09-300001387131-14-003647
2014-11-0616:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-14-003626
2014-08-0716:44 ET10-QQuarterly reportPeriod 2014-06-300001387131-14-002744
2014-08-0616:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-14-002712
2014-08-0416:21 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-14-293543
2014-07-3016:48 ET8-K8.01 Other events0001193125-14-287056
2014-06-1116:45 ET8-K5.07 Shareholder vote results0001387131-14-002185
2014-05-0708:52 ET10-QQuarterly reportPeriod 2014-03-310001387131-14-001673
2014-05-0607:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-14-001658
2014-05-0516:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-14-001651
2014-04-1717:02 ETDEF 14AProxy statementPeriod 2014-06-050001193125-14-147850
2014-04-0816:56 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-14-001325
2014-03-2815:15 ET8-K7.01 Regulation FD disclosure0001193125-14-121163
2014-03-2116:46 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-14-110466
2014-03-0517:10 ET10-KAnnual reportPeriod 2013-12-310001387131-14-000771
2014-03-0416:50 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-14-000739
2014-03-0316:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-14-000717
2013-12-1808:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001387131-13-004709
2013-11-2716:18 ETSC 13D/AOwnership report, active investor, amended0001387131-13-004524
2013-11-2716:16 ETSC 13D/AOwnership report, active investor, amended0001387131-13-004522
2013-11-0617:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-13-004117
2013-11-0507:11 ET10-QQuarterly reportPeriod 2013-09-300001387131-13-004064
2013-11-0417:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-13-004055
2013-10-0817:46 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-13-003747
2013-09-2517:11 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-13-378619
2013-09-2509:30 ET8-K8.01 Other events0001193125-13-377277
2013-09-2417:02 ET8-K8.01 Other events0001193125-13-376468
2013-08-2817:11 ETSC 13D/AOwnership report, active investor, amended0001387131-13-003202
2013-08-2216:57 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001387131-13-003145
2013-08-0706:07 ET10-QQuarterly reportPeriod 2013-06-300001387131-13-002760
2013-08-0608:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-13-002719
2013-07-1206:06 ETDEF 14AProxy statementPeriod 2013-08-220001193125-13-288738
2013-06-1408:04 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-13-002200
2013-06-0417:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-13-002092

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.